BOISE CITY, ID, September 11, 2013 /24-7PressRelease/
-- For the past several years, Douglas O'Coyne Jr.
has played an integral part in developing genetic tests to help medical professionals assess patients' cancer risks. Working at Myriad Genetics, Douglas has learned the importance of cancer screenings and how much of an impact they can have on someone's life. But most people still seem to be unaware of the advantages of early cancer screenings. They will refuse to seek assistance from a healthcare provider, mostly because they are not familiar with the procedure. A lot of cancer screenings are very simple and present little hassle.
in the San Francisco Chronicle describes how a common cancer screening that people tend to neglect is a colonoscopy. Patients are uncomfortable seeking help with colon cancer check-ups. However, studies show that colon cancer is actually the third-leading cause of cancer-related deaths in the United States among both men and women. By the end of 2013, there will be an estimated 50,830 deaths related to this type of cancer. Getting a colonoscopy can catch the cancer early on and help save a patient's life. Douglas O'Coyne has provided some insight and addressed the most common concerns regarding the procedure.
Colonoscopies have become such a common practice in the United States because of their high success rates. Over 90 percent of colon cancer diagnoses are preventable if they are caught early. Each year, roughly 130,000 Americans are diagnosed with colon cancer and two thirds of them survive thanks to early detection. Colonoscopy has reduced death rates because it catches the symptoms and signs before the cancer reaches an advanced stage.
A lot of patients will be wary about going in for a procedure if they think there will be pain or discomfort. Doctors ensure that patients are comfortable during their colonoscopy by administering anesthetics. Some procedures will require the patient to be unconscious; however, there are doctors who allow for local anesthetics to be provided. A few patients like to be awake so that they can ask questions throughout the test.
Douglas O'Coyne Jr. points out that the procedure does not take very long. A majority of patients are in and out of the office within two hours. This time span includes checking in, starting an IV, being put under sedation, conducting the procedure, and then allowing the patient to recover. The actual colonoscopy itself only takes about 15-20 minutes.
"There are very minimal complications when it comes to colonoscopy. The only risk is a perforation, which is a hole being poked in the colon. But the risk of this happening is at about 0.08 percent. So, you are more likely to die in a car crash than having your colon perforated," explains Douglas O'Coyne Jr.
Douglas O'Coyne Jr.
is an account executive with Myriad Genetics. His responsibilities at this company include increasing the number of genetic and personalized medicine test samples for Myriad Genetics Laboratory. His efforts led to a revenue increase from $45,000 to $545,000 from March 2011 to March 2012. Not only this, he was also voted MVP during Phase II and Phase III of his training classes among 20 other individuals. Prior to Myriad Genetics, Douglas worked as an authorized Aflac agent and supervisor of network operations at Qwest in the Boise, Idaho area. Douglas served as a Platoon Leader in the United States Army between May 2005 and May 2007.